AI assistant
Sending…
LEAP THERAPEUTICS, INC. — Director's Dealing 2021
Sep 28, 2021
35080_dirs_2021-09-28_117fd34e-ba13-4d63-ba1e-c01a042b1f60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEAP THERAPEUTICS, INC. (LPTX)
CIK: 0001509745
Period of Report: 2021-09-24
Reporting Person: BeiGene, Ltd. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-24 | Common Stock | P | 2543800 | $2.85 | Acquired | 7348437 | Direct |
Footnotes
F1: On September 24, 2021, BeiGene, Ltd. purchased 2,543,800 shares of common stock of the Issuer for $2.85 per share pursuant to an underwritten public offering.
More from LEAP THERAPEUTICS, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Board/Management Information
2026
Apr 10
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17